Syndax Pharmaceuticals Inc (35) | Business Finance (14)

Browse by Subcategory

Recent Contracts

First Amendment to the Companys Loan and Security Agreement with the several banks and financial institutions or entities from time-to-time party thereto and Hercules Capital,... (Filed With SEC on March 1, 2022)
Form of Pre-Funded Warrant (2021) (Filed With SEC on December 17, 2021)
Underwriting Agreement, dated December 15, 2021, by and among the Company and Goldman Sachs & Co. LLC (Filed With SEC on December 17, 2021)
Stock Purchase Agreement by and between the Company and Incyte Corporation, dated as of September 24, 2021 (Filed With SEC on November 15, 2021)
Purchase Agreement between the Company and the Purchasers, dated January 30, 2020 (Filed With SEC on February 4, 2020)
Underwriting Agreement, dated December 8, 2020, by and among the Company, Goldman Sachs & Co. LLC, Citigroup Global Markets Inc. and Cowen and Company, LLC (Filed With SEC on December 9, 2020)
Loan and Security Agreement dated February 7, 2020 between Syndax Pharmaceuticals, Inc. and Hercules Capital, Inc (Filed With SEC on May 7, 2020)
Underwriting Agreement, dated April 30, 2020, by and among the Company, Citigroup Global Markets Inc. and Cowen and Company, LLC (Filed With SEC on May 4, 2020)
Description of Capital Stock (Filed With SEC on March 5, 2020)
Form of Pre-Funded Warrant (Filed With SEC on February 4, 2020)
Form of Series Warrant (Filed With SEC on March 29, 2019)
Form of Pre-Funded Warrant (Filed With SEC on March 29, 2019)
Purchase Agreement between the Company and the Purchasers, dated March 26, 2019 (Filed With SEC on March 29, 2019)
Purchase Agreement between the Company and the Purchaser, dated March 28, 2019 (Filed With SEC on March 29, 2019)